CRISPR THERAPEUTICS
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98164704
- Registration number
- 7701013
- Mark type
- Stylized text
- Filed
- 05 Sept 2023
- Published for opposition
- 07 Jan 2025
- Registered
- 25 Feb 2025
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
Owner
- CRISPR Therapeutics AG, ZUG V8, CH
- CRISPR Therapeutics AG, ZUG V8, CH
- CRISPR Therapeutics AG, ZUG V8, CH
Prosecution history
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Dec 2024 — EXAMINER'S AMENDMENT ENTERED
- 06 Dec 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 06 Dec 2024 — EXAMINERS AMENDMENT E-MAILED
- 06 Dec 2024 — EXAMINERS AMENDMENT -WRITTEN
- 07 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 May 2024 — NON-FINAL ACTION E-MAILED